+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Peptide Therapeutics Market 2020-2026

  • ID: 5145129
  • Report
  • July 2020
  • Region: Global
  • Orion Market Research Private Limited
UP TO OFF
until Dec 31st 2021
1 of 3

FEATURED COMPANIES

  • Amgen, Inc.
  • Bachem Holding AG
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Novo Nordisk A/S
  • MORE
Global Peptide Therapeutics Market Size, Share & Trends Analysis Report by Route of Administration (Oral and Parenteral), by Application (Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, Respiratory Disorders, and Others), Forecast 2020-2026.

The global peptide therapeutics market is projected to grow at a significant CAGR during the forecast period. The key factors that drive the growth of the market include the increased incidences of several disorders such as cancer, gastrointestinal disorders, central nervous system disorders, respiratory disorders, and others; along with the availability and development of advanced drugs for the treatment. Further, the growth of the market is also associated with the increased investments in the R&D for the drug discovery and presence of strong product pipeline in the market. Further, the increased clinical trials in the market also drives the global peptide therapeutics market during the forecast period.

The global peptide therapeutics market is segmented on the basis of route of administration and application. Based on the route of administration, the market is bifurcated into oral and parenteral. Based on the application, the market is segmented into cancer, gastrointestinal disorders, central nervous system disorders, respiratory disorders, and others. Peptide therapeutics for cancer tend to contribute a considerable share to the market growth. Respiratory disorders segment is projected to exhibit considerable growth rate during the forecast period.

Geographically, the study of the global peptide therapeutics market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. North America is estimated to contribute a significant share in the market. While Asia-Pacific is estimated to exhibit a considerable growth rate during the forecast period.

Further, Amgen Inc., Eli Lilly and Co., Pfizer, Inc., Bristol-Myer Squibb Co., AstraZeneca Plc, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis International AG, Novo Nordisk A/S, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceuticals Industries Ltd., and others are some of the prominent players operating in the global peptide therapeutics market.

Research Methodology

The market study of the global peptide therapeutics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report is intended for pharmaceutical companies, drug manufacturers, active pharmaceutical ingredient manufacturers, raw material suppliers, traders, research institutes, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. Global Peptide Therapeutics Market Research and Analysis by Route of Administration
2. Global Peptide Therapeutics Market Research and Analysis by Application

The Report Covers
  • Comprehensive research methodology of the global peptide therapeutics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global peptide therapeutics market.
  • Insights about market determinants which are stimulating the global peptide therapeutics market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of the market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amgen, Inc.
  • Bachem Holding AG
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Novo Nordisk A/S
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Amgen Inc.
3.1.1.1. Overview
3.1.1.2. Financial Analysis
3.1.1.3. SWOT Analysis
3.1.1.4. Recent Developments
3.1.2. Eli Lilly and Co.
3.1.2.1. Overview
3.1.2.2. Financial Analysis
3.1.2.3. SWOT Analysis
3.1.2.4. Recent Developments
3.1.3. Pfizer Inc.
3.1.3.1. Overview
3.1.3.2. Financial Analysis
3.1.3.3. SWOT Analysis
3.1.3.4. Recent Developments
3.1.4. Bristol-Myers Squibb Co.
3.1.4.1. Overview
3.1.4.2. Financial Analysis
3.1.4.3. SWOT Analysis
3.1.4.4. Recent Developments
3.2. Key Strategy Analysis

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Peptide Therapeutics Market by Route of Administration
5.1.1. Oral
5.1.2. Parenteral
5.2. Global Peptide Therapeutics Market by Application
5.2.1. Cancer
5.2.2. Gastrointestinal Disorders
5.2.3. Central Nervous System Disorders
5.2.4. Respiratory Disorders
5.2.5. Others

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Amgen, Inc.
7.2. AstraZeneca Plc
7.3. Bachem Holding AG
7.4. Bristol-Myers Squibb Co.
7.5. CordenPharma InternationalGmbH
7.6. Eli Lilly and Co.
7.7. F. Hoffmann-La Roche Ltd.
7.8. GlaxoSmithKline Plc
7.9. Lonza Group AG
7.10. Merck & Co. Inc.
7.11. Novartis International AG
7.12. Novo Nordisk A/S
7.13. Pfizer, Inc.
7.14. PolyPeptide Group
7.15. Sanofi SA
7.16. Takeda Pharmaceutical Co. Ltd.
7.17. Teva Pharmaceuticals Industries Ltd.
7.18. Xenetic Biosciences, Inc.

LIST OF TABLES
1. GLOBAL PEPTIDE THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
2. GLOBAL PEPTIDE THERAPEUTICS VIA ORAL ROUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. GLOBAL PEPTIDE THERAPEUTICS VIA PARENTERAL ROUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. GLOBAL PEPTIDE THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
5. GLOBAL PEPTIDE THERAPEUTICS FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
6. GLOBAL PEPTIDE THERAPEUTICS FOR GASTROINTESTINAL DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
7. GLOBAL PEPTIDE THERAPEUTICS FOR CENTRAL NERVOUS SYSTEM DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
8. GLOBAL PEPTIDE THERAPEUTICS FOR RESPIRATORY DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
9. GLOBAL PEPTIDE THERAPEUTICS FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
10. GLOBAL PEPTIDE THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
11. NORTH AMERICAN PEPTIDE THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
12. NORTH AMERICAN PEPTIDE THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
13. NORTH AMERICAN PEPTIDE THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
14. EUROPEAN PEPTIDE THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
15. EUROPEAN PEPTIDE THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
16. EUROPEAN PEPTIDE THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
17. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
18. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
19. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
20. REST OF THE WORLD PEPTIDE THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
21. REST OF THE WORLD PEPTIDE THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)

LIST OF FIGURES
1. GLOBAL PEPTIDE THERAPEUTICS MARKET SHARE BY ROUTE OF ADMINISTRATION, 2019 VS 2026 (%)
2. GLOBAL PEPTIDE THERAPEUTICS MARKET SHARE BY APPLICATION, 2019 VS 2026 (%)
3. GLOBAL PEPTIDE THERAPEUTICS MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
4. US PEPTIDE THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
5. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
6. UK PEPTIDE THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
7. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
8. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
9. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
10. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
11. ROE PEPTIDE THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
12. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
13. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
14. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
15. REST OF ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
16. REST OF THE WORLD PEPTIDE THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
Note: Product cover images may vary from those shown
3 of 3
  • Amgen, Inc.
  • AstraZeneca Plc
  • Bachem Holding AG
  • Bristol-Myers Squibb Co.
  • CordenPharma International GmbH
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Lonza Group AG
  • Merck & Co. Inc.
  • Novartis International AG
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • PolyPeptide Group
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Xenetic Biosciences, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll